Impaired collateral vessel development in diabetes: Potential cellular mechanisms and therapeutic implications

Cardiovascular Research

Volumn 49, Issue 3, 2001, Pages 554-560

  Waltenberger, Johannes ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Angiogenesis; Collateral circulation; Diabetes; Growth factors; Signal transduction

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTERIOLE; CAPILLARY; CELL FUNCTION; CELL INFILTRATION; COLLATERAL CIRCULATION; DIABETES MELLITUS; HEART MUSCLE ISCHEMIA; HUMAN; MONOCYTE; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION;

AGED; ANIMALS; CELL MOVEMENT; COLLATERAL CIRCULATION; CORONARY DISEASE; CYTOKINES; DIABETES MELLITUS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035895708     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00228-5     Document Type: Review

References (35)

1. Serial angiographic assessment of coronary artery obstruction and collateral flow in myocardial infarction. Report from the second Mount Sinai -New York University Reperfusion Trial
2. Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion
3. DNA-synthesis and mitoses in coronary collateral vessels in the dog
4. Molecular mechanisms of coronary collateral vessel growth
5. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion
6. Functional importance of the human coronary collateral circulation
7. Influence of coronary collateral vessels on myocardial infarct size in humans, results of phase I thrombolysis in myocardial infarction (TIMI) trial
8. Functional significance of coronary collateral vessels in patients with acute myocardial infarction. Relation to pump performance, cardiogenic shock and survival
9. Coronary collateral circulation, clinical significance and influence on survival in patients with coronary artery disease
10. Effects of immature recruitable collaterals on myocardial blood flow and infarct size after acute coronary occlusion
11. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
12. Vascular dysfunction in diabetes mellitus
13. Endothelial dysfunction Is detectable in young normotensive first-degree relatives of subjects With type 2 diabetes in association with insulin resistance
14. Effect of diabetes mellitus on formation of coronary collateral vessels
15. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion
16. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb
17. Shear stress-mediated changes in the expression of leukocyte adhesion receptors on human umbilical vein endothelial cells in vitro
18. The vascular endothelial growth factor receptor FLT-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
19. Different signal transduction properties of K.D.R. and Flt1, two receptors for vascular endothelial growth factor
20. Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance
21. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
22. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
23. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury
24. Vascular endothelial growth factor-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus. A potential predictor for the individual capacity to develop collaterals
25. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
26. Human coronary artery endothelial cells express functional receptors for VEGF in vitro and in vivo
27. 1 expression in vivo
28. Vascular endothelial growth factor activates nuclear factor-κB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells
29. Differential expression of PDGF A- and B-chain genes and production of AA and AB dimers by activated human blood monocytes
30. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
31. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGf expression only
32. Age-dependent impairment of angiogenesis
33. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial
34. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with Adeno-VEGF
35. Hyperlipidemic endothelial injury and angiogenesis